W. Alberto Sifuentes Giraldo: Non-Criteria Manifestations of Antiphospholipid Syndrome
W. Alberto Sifuentes Giraldo, Rheumatologist at Hospital Nuestra Señora de Sonsoles (Sacyl), shared a post on X:
”Although the classification criteria for antiphospholipid syndrome (APS) classically require the presence of a thrombotic event in the venous vascular territory (e.g., deep vein thrombosis) or arterial territory (e.g., myocardial infarction, stroke), or recurrent fetal loss, this does not mean that patients with positive antiphospholipid antibodies who do not meet these criteria do not have this disorder.
The spectrum of APS manifestations is broad and encompasses several other symptoms that are not criteria, such as cutaneous manifestations including livedo reticularis, necrotic ulcers, pseudovasculitic lesions, digital gangrene, and splinter hemorrhages, among others.
The presence of antiphospholipid antibodies can also be associated with other symptoms, such as thrombocytopenia, valvular heart disease, epilepsy, or transverse myelitis. Furthermore, it carries an increased risk of other autoimmune disorders. In half of the cases, APS is associated with other autoimmune rheumatic diseases, the most frequent being systemic lupus erythematosus.
Non-Criteria Manifestations of Antiphospholipid Syndrome (APS). Adapted from: Pires da Rosa G, Espinosa G, Cervera R.
Non-criteria manifestations of antiphospholipid syndrome: an overview. Span J Med. 2021;1(2).”
Stay updated with Hemostasis Today.
-
Nov 2, 2026, 22:12Annie Bauzon: How the Body Produces Millions of Blood Cells Every Day
-
Nov 2, 2026, 22:11Anna Supernat: Does Leukocyte-Associated RNA Retention Affect Platelet-Based Cancer Classification?
-
Nov 2, 2026, 22:07Aabha Divya: Late Biatrial Thrombosis 31 Years After Heart Transplantation
-
Nov 2, 2026, 22:01Sakditad Saowapa: Anticoagulant Pharmacology and the Pursuit of Effective Therapy With Less Bleeding
-
Nov 2, 2026, 21:55Lucio D’Anna: Can Inflammatory Biomarkers Identify Residual Risk in Atrial Fibrillation?
-
Nov 2, 2026, 21:54Dawood Findakly: VTE Prophylaxis during Pregnancy
-
Nov 2, 2026, 21:52N. Mariana S. Vasquez: Five Rules That Help Identify the Cause of Hemolytic Anemia
-
Nov 2, 2026, 21:52Rob Maloney: Working Together to Strengthen Bleeding Disorders Care in the Dominican Republic
-
Nov 2, 2026, 18:08Jonathan Penm: Antithrombotic Stewardship Optimizes VTE Prophylaxis in ICU Patients